Return to: Medical School : Academic Health Center : myU : U of M Home

Gold University of Minnesota M. Skip to main content. Link to University of Minnesota homepage
Division of Hematology, Oncology, and Transplantation (HOT)
Whats Inside
Clinics

Contact Us

Education

Faculty

Fellow Bios

Links

Make a Gift

Minnesota Masons - A Legacy of Giving

Nurse Practitioners and Physician Assistants

Research Activities

Researchers

Schedules

Stem Cell Institute

Vascular Biology Center

Visitors

 

HOT Home

Masonic Clinic

Home > Faculty > Mukta Arora, M.D., M.S.

Printer-friendly version   Mail this page to a friend

Mukta Arora, M.D., M.S.


Dr. Arora is an Assistant Professor in the Division of Hematology, Oncology and Transplantation, Department of Medicine. Dr. Arora received her MBBS and M.D. degrees from University of Lucknow and University of Kanpur, India, in 1993 and 1997, respectively. She then completed both residency and fellowship training in Hematology, Oncology and Transplantation from the University of Minnesota in 2002.

Dr. Arora's clinical interest is in treatment of hematologic malignancies and blood and marrow transplantation. Her research interests focus on studying new therapies for management of Chronic Graft versus Host Disease (CGVHD) and methods to improve outcomes following transplantation therapy for Multiple Myeloma.

Selected Publications

Arora M, Wagner JE, Davis SM, Blazar BR, Defor T, Enright H, Miller WJ, Weisdorf DJ. Randomized clinical trial of Thalidomide, Cyclosporine and Prednisone vs Cyclosporine and Prednisone as initial therapy in CGVHD. Biol Blood Marrow Transplant 2001;7:265-73.

Arora M, Burns LJ, Davis SM, MacMillan ML, Miller WJ, DeforTE, Weisdorf DJ. CGVHD: A prospective cohort study. Biol Blood Marrow Transplant 2003;9:38-45.

Akpek G, Lee SJ, Flowers ME, Pavletic SZ, Arora M, Piantadosi S, Guthrie KA, Lynch JC, Takatu A, Horowitz MM, Antin JH, Weisdorf DJ, Martin PJ, Vogelsang GB. Multi-center validation of a new prognostic grading in chronic graft-versus-host-disease. Blood 2003;102:802-9.

Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.  Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.  Biol Blood Marrow Transplant 2004; 10:395-404.

Laudi N, Arora M, Burns L, McGlave P, Miller J, Bohac G, Rogers T, Barker J, Coad J, Weisdorf D. Efficacy of high-dose therapy and hematopoietic stem cell transplantation for mantle cell lymphoma. Am J Hematol. 2006; 81:519-24.

Fraser CJ, Bhatia S, Ness K, Carter A, Francisco L, Arora M, Parker P, Forman S, Weisdorf D, Gurney JG, Baker KS. Impact of chronic graft versus host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study. Blood. 2006 Jun 20; [Epub ahead of print]


Feedback | Notice of Privacy Practices


 
The University of Minnesota is an equal opportunity educator and employer.